All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 147 of 206 pages ‹ First < 145 146 147 148 149 > Last ›
HSL17939
 Brummer A
 Glaxo faces storm over Seroxat
 This is LONDON 2003 Jun 9
 
http://www.thisislondon.co.uk/news/article-5225088-glaxo-faces-storm-over-seroxat.do
HSL18173
 Rawson NSB
 Timeliness of review and approval of new drugs in Canada from 1999 through 2001: Is progress being made?
 Clinical Therapeutics 2003 Jun 8;25:(4):1230-1247
 
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRS-48SYGHV-H&_user=10&_handle=W-WA-A-A-AY-MsSAYVA-UUW-AUCDBEVCEY-AWEDZCWBY-AY-U&_fmt=summary&_coverDate=04/30/2003&_rdoc=15&_orig=browse&_srch=#toc#6242#2003#999749995#433824!&_cdi=6242&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=44d8db016d92307ccdc9decbb7b6a71f
HSL10414
 Renton S.
 Dressing down.
 
Vet Rec 2003 Jun 7;152:(23):724
 
HSL18126
 Watson R.
 EU agrees deal on cheaper drugs for developing world.
 BMJ 2003 Jun 7;326:(7401):1229
 
http://www.bmj.com/cgi/content/full/326/7401/1229-a?view=long&pmid=12791716
HSL18127
 Raufu A.
 India agrees to help Nigeria tackle the import of fake drugs.
 BMJ 2003 Jun 7;326:(7401):1234
 
http://www.bmj.com/cgi/content/full/326/7401/1234-d?view=long&pmid=12791732
HSL18128
 Charatan F.
 Schering-Plough is accused of overcharging and of obstructing justice.
 BMJ 2003 Jun 7;326:(7401):1233
 
http://www.bmj.com/cgi/content/full/326/7401/1233?view=long&pmid=12791730
HSL1277
 Children 'should not take Seroxat'
 BBC News 2003 Jun 6
 
http://news.bbc.co.uk/2/hi/health/2976498.stm
HSL1268
 Goldstein A.
 Edwards to Offer Health Plan
 The Washington Post 2003 Jun 5
 
HSL1270
 Espo D.
 Medicare Deal Would Offer Equal Coverage
 Associated Press 2003 Jun 5
 
HSL1274
 Strom S.
 Company's Pledge to Donate a Cancer Drug Is Falling Short
 New York Times 2003 Jun 5
 
HSL1275
 Argentia's Largest Health System Pioneers Innovative Approach To Lower Drug Costs
 Pan American Health Organisation 2003 Jun 5
 
HSL1276
 Boseley S.
 Prozac made librarian kill herself, says psychiatrist
 The Guardian 2003 Jun 5
 
http://www.guardian.co.uk/news/2003/jun/05/medicineandhealth
HSL1266
 Duenwald M.
 Study Says Drug Group Can't Help Alzheimer's
 The New York Times 2003 Jun 4
 
http://www.nytimes.com/2003/06/04/us/study-says-drug-group-can-t-help-alzheimer-s.html
HSL1267
 Wardle A.
 Tennesseans file Paxil suit
 The Nashville City Paper 2003 Jun 4
 
http://nashvillecitypaper.com/content/city-news/tennesseans-file-paxil-suit
HSL18129
 Mitka M
 FDA Issues Warning on 'All-Natural' Herbal Product Found to Contain Viagra
 JAMA 2003 Jun 4;289:(21):2786
 
http://jama.ama-assn.org/cgi/content/full/289/21/2786
HSL1265
 Barclay L.
 BMJ: Pharmaceutical Industry-Physician
 Medscape Medical News 2003 Jun 3
 
http://www.medscape.com/viewarticle/456554
HSL1262
 Tozer J.
 Man slashed wrists after two weeks on anxiety pill: Coroner calls for leading anti-depressant to be withdrawn
 femail.co.uk 2003 Jun 2
 
HSL1263
 Prozac could fight cancer
 femail.co.uk 2003 Jun 2
 
HSL1264
 Harney T.
 Prozac Killed My Wife
 Leeds Today 2003 Jun 2
 
HSL423
 Mansfield PR.
 Bribes for doctors: a gift for bioethicists?
 Am J Bioeth 2003 Summer;3:(3):47-8
 
HSL1261
 Retsinas G.
 The Marketing of a Superbaby Formula
 The New York Times 2003 Jun 1
 
http://www.nytimes.com/2003/06/01/business/the-marketing-of-a-superbaby-formula.html
HSL5430
 Rosenthal M, Berndt ER, Donohue JM, Epstein AM, Frank RG
 Demand Effects of Recent Changes in Prescription Drug Promotion
 : Kaiser Family Foundation 2003 Jun 1
 
http://www.kff.org/rxdrugs/upload/Demand-Effects-of-Recent-Changes-in-Prescription-Drug-Promotion-Report.pdf
HSL11640
 Hedgecoe A, Martin P.
 The Drugs Don't Work : Expectations and the Shaping of Pharmacogenetics 
 Social Studies of Science 2003 Jun 1;33:(3):327-364
 
http://sss.sagepub.com/cgi/content/abstract/33/3/327
HSL1213
 Fugh-Berman A.
 "Bust enhancing" herbal products.
 Obstet Gynecol 2003 Jun;101:(6):1345-9
 
http://www.greenjournal.org/cgi/content/full/101/6/1345
HSL1244
 Bernardini C, Ambrogi V, Perioli L.
 Drugs and non-medical products sold in pharmacy: information and advertising.
 Pharmacol Res 2003 Jun;47:(6):501-8
 
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WP9-486G69M-5&_coverDate=06%2F30%2F2003&_alid=272785450&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6985&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0b69bc84958df05d73a1c8ab7d0385f5
HSL1260
 Napoli M.
 Cholesterol Skeptics And The Bad News About Statin Drugs
 Centre for Medical Consumers 2003 Jun
 
http://medicalconsumers.org/2003/06/01/cholesterol-skeptics-conference-report/
HSL1326
 Elder E.
 A Sucker Punch At The Drug Industry: Book Review
 Health Affairs 2003 Jun
 
http://content.healthaffairs.org/cgi/content/full/22/4/252
HSL1907
 O'Reilly J, Dalal A.
 Off-label or out of bounds? Prescriber and marketer liability for unapproved uses of FDA-approved drugs
 Ann Health Law. 2003 Summer;12:(2):295-324
 
HSL10252
 Cutts C, Tett SE.
 Influences on doctors' prescribing: is geographical remoteness a factor?
 
Aust J Rural Health 2003 Jun;11:(3):124-30
 
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1440-1584.2003.00502.x
HSL10358
 Wysowski DK, Armstrong G, Governale L.
 Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001.
 
Diabetes Care 2003 Jun;26:(6):1852-5
 
http://care.diabetesjournals.org/cgi/content/full/26/6/1852
HSL10410
 Bergmann JF.
 Self-medication: from European regulatory directives to therapeutic strategy.
 
Fundam Clin Pharmacol 2003 Jun;17:(3):275-80
 
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1472-8206.2003.00141.x
HSL10415
 Israel R.
 The relationship between physicians and industry: Faustian or symbiotic?
 
Am J Obstet Gynecol 2003 Jun;188:(6):1530-40
 
http://linkinghub.elsevier.com/retrieve/pii/S0002937803003405
HSL10424
 Moore N, Hall G, Sturkenboom M, Mann R, Lagnaoui R, Begaud B.
 Biases affecting the proportional reporting ratio (PPR) in spontaneous reports pharmacovigilance databases: the example of sertindole.
 
Pharmacoepidemiol Drug Saf 2003 Jun;12:(4):271-81
 
HSL10425
 Ko R, Wilson RD, Loscutoff S.
 PC-SPES.
 
Urology 2003 Jun;61:(6):1292
 
HSL10470
 Askmark H, Antonov K, Aquilonius SM.
 The increased utilisation of dopamine agonists and the introduction of COMT inhibitors have not reduced levodopa consumption--a nation-wide perspective in Sweden.
 
Parkinsonism Relat Disord 2003 Jun;9:(5):271-6
 
http://linkinghub.elsevier.com/retrieve/pii/S1353802002001177
HSL1168
 Pear R.
 Drug Companies Increase Spending to Lobby Congress and Governments
 The New York Times 2003 May 31
 
HSL1170
 Peterson M.
 Big Drug Company Says It May Face Obstruction Case
 The New York Times 2003 May 31
 
HSL1193
 Lexchin J, Bero LA, Djulbegovic B, Clark O.
 Pharmaceutical industry sponsorship and research outcome and quality: systematic review.
 BMJ 2003 May 31;326:(7400):1167-70
 
http://bmj.bmjjournals.com/cgi/content/full/326/7400/1167
HSL1915
 Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B.
 Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.
 BMJ 2003 May 31;326:(7400):1171-3
 
http://bmj.bmjjournals.com/cgi/content/full/326/7400/1171
HSL2138
 Watkins C, Moore L, Harvey I, Carthy P, Robinson E, Brawn R.
 Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study.
 BMJ 2003 May 31;326:(7400):1178-9
 
http://bmj.bmjjournals.com/cgi/content/full/326/7400/1178
HSL2153
 Moynihan R.
 Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement.
 BMJ 2003 May 31;326:(7400):1193-6
 
http://bmj.bmjjournals.com/cgi/content/full/326/7400/1193
HSL2154
 Liberati A, Magrini N.
 Information from drug companies and opinion leaders.
 BMJ 2003 May 31;326:(7400):1156-7
 
http://bmj.bmjjournals.com/cgi/content/full/326/7400/1156
HSL2155
 Herxheimer A.
 Relationships between the pharmaceutical industry and patients' organisations.
 BMJ 2003 May 31;326:(7400):1208-10
 
http://bmj.bmjjournals.com/cgi/content/full/326/7400/1208
HSL2159
 Burton B, Rowell A.
 Unhealthy spin.
 BMJ 2003 May 31;326:(7400):1205-7
 
http://bmj.bmjjournals.com/cgi/content/full/326/7400/1205
HSL10465
 Hirst J.
 Charities and patient groups should declare interests.
 
BMJ 2003 May 31;326:(7400):1211
 
http://www.bmj.com/cgi/content/full/326/7400/1211-a
HSL10466
 Oliver JJ, Maxwell SR.
 Journals should select drug advertisements more carefully.
 
BMJ 2003 May 31;326:(7400):1211
 
http://www.bmj.com/cgi/content/full/326/7400/1211
HSL18130
 Abbasi K, Smith R.
 No more free lunches.
 BMJ 2003 May 31;326:(7400):1155-6
 
http://www.bmj.com/cgi/content/full/326/7400/1155?view=long&pmid=12775587
HSL18131
 Faulkner A, Geesink I, Kent J, FitzPatrick D.
 Human tissue engineered products--drugs or devices?
 BMJ 2003 May 31;326:(7400):1159-60
 
http://www.bmj.com/cgi/content/full/326/7400/1159?view=long&pmid=12775590
HSL18132
 Moynihan R
 Drug company secretly briefed medical societies on HRT
 BMJ 2003 May 31;326:(7400):1161
 
http://www.bmj.com/cgi/content/full/326/7400/1161
HSL18133
 Koch K
 Schering uses German medical association to promote HRT
 BMJ 2003 May 31;326:(7400):1161
 
http://www.bmj.com/cgi/content/full/326/7400/1161-a
HSL18134
 Moynihan R.
 Drug company sponsorship of education could be replaced at a fraction of its cost.
 BMJ 2003 May 31;326:(7400):1163
 
http://www.bmj.com/cgi/content/full/326/7400/1163-a?view=long&pmid=12775595
HSL18135
 Drug companies advised to publish unfavourable trial results
 BMJ 2003 May 31;326:(7400):1163
 
http://www.bmj.com/cgi/content/full/326/7400/1163-a
HSL18136
 Mayor S.
 World Medical Association reviews doctors' links with drug companies.
 BMJ 2003 May 31;326:(7400):1165
 
http://www.bmj.com/cgi/content/full/326/7400/1165-a?view=long&pmid=12775604
HSL18137
 Wager E.
 How to dance with porcupines: rules and guidelines on doctors' relations with drug companies.
 BMJ 2003 May 31;326:(7400):1196-8
 
http://www.bmj.com/cgi/content/full/326/7400/1196?view=long&pmid=12775623
HSL18138
 Garattini S, Bertele V, Li Bassi L.
 How can research ethics committees protect patients better?
 BMJ 2003 May 31;326:(7400):1199-201
 
http://www.bmj.com/cgi/content/full/326/7400/1199?view=long&pmid=12775624
HSL18139
 Smith R.
 Medical journals and pharmaceutical companies: uneasy bedfellows.
 BMJ 2003 May 31;326:(7400):1202-5
 
http://www.bmj.com/cgi/content/full/326/7400/1202?view=long&pmid=12775625
HSL18144
 Neville E.
 British Thoracic Society corrects damaging impression.
 BMJ 2003 May 31;326:(7400):1211-2
 
http://bmj.com/cgi/content/full/326/7400/1211-c
HSL18145
 Napier JC, Francis R, Wright G.
 Shared scheme for assessing drugs for multiple sclerosis: cost effective provision of effective treatments for multiple sclerosis.
 BMJ 2003 May 31;326:(7400):1212
 
http://www.bmj.com/cgi/content/full/326/7400/1212?view=long&pmid=12775633
HSL18146
 Chadwick D, Gray R.
 Shared scheme for assessing drugs for multiple sclerosis: dealing with uncertainties about cost effectiveness of treatments is difficult problem.
 BMJ 2003 May 31;326:(7400):1212-3
 
http://www.bmj.com/cgi/content/full/326/7400/1212-a?view=long&pmid=12775632
HSL1166
 Doctors 'influenced by drug companies'
 BBC News 2003 May 30
 
http://news.bbc.co.uk/2/hi/health/2946276.stm
HSL5478
 Mansfield PR.
 Free offer for all BMJ readers from Healthy Skepticism
 BMJ 2003 May 30;326:
 
http://bmj.bmjjournals.com/cgi/eletters/326/7400/1205
HSL7453
 Petersen M.
 Court Papers Suggest Scale Of Drug's Use 
 New York Times 2003 May 30
 
http://query.nytimes.com/gst/fullpage.html?sec=health&res=9502E6DD1630F933A05756C0A9659C8B63
HSL10473
 Steinbrook R.
 HIV infection--a new drug and new costs.
 
N Engl J Med 2003 May 29;348:(22):2171-2
 
http://content.nejm.org/cgi/content/extract/348/22/2171
HSL17938
 Simmons Hotz A
 Poison for Profit - What A Business Plan!
 Mercola.com 2003 May 29
 
HSL18147
 Moynihan R
 The Big Fix: How the Pharmaceutical Industry Rips Off American Consumers
 BMJ 2003 May 29;326:(7400):1218
 
http://www.bmj.com/cgi/content/full/326/7400/1218
HSL18148
 Jackson T
 Regulator spells out rules on disease awareness campaigns
 BMJ 2003 May 29;326:(7400):1219
 
http://www.bmj.com/cgi/content/full/326/7400/1219-a
HSL18149
 Bonaccorso S, Smith R
 In praise of the 'devil'
 BMJ 2003 May 29;326:(7400):1220
 
http://www.bmj.com/cgi/content/full/326/7400/1220
HSL18150
 Müllner M
 Doctors and the drug industry
 BMJ 2003 May 29;326:(7400):1220
 
http://www.bmj.com/cgi/content/full/326/7400/1220-a
HSL18151
 Belcher P
 How not to do medical research
 BMJ 2003 May 29;326:(7400):1221
 
http://www.bmj.com/cgi/content/full/326/7400/1221
HSL1160
 Moynihan R.
 The shocking truth on HRT
 The Age (Melbourne, Australia) 2003 May 28
 
http://www.theage.com.au/articles/2003/05/27/1053801392049.html
HSL1162
 Grady D.
 Hormone Use Found to Raise Dementia Risk
 The New York Times 2003 May 28
 
http://www.nytimes.com/2003/05/28/us/hormone-use-found-to-raise-dementia-risk.html?pagewanted=1
HSL1165
 Vergano D.
 Little children suffer in search for cures
 USA TODAY 2003 May 28
 
HSL1158
 Schiff I.
 More bad news for hormone therapy: Study finds treatment may increase risk of dementia
 Associated Press 2003 May 27
 
HSL1159
 Hormone Therapy Doubles Risk Of Dementia: Network Calls For Curbs On Drug Company Influence Over Prescribing
 National Women's Health Network 2003 May 27
 
HSL1154
 Buck T.
 EU acts to speed up flow of cheap Aids drugs
 2003 May 26
 
HSL1156
 Quinn E.
 Drugs giant to face Irish Seroxat lawsuits
 The Sunday Business Post 2003 May 26
 
HSL1151
 Kowalczyk L.
 Drug companies' secret reports outrage doctors
 Boston Globe 2003 May 25
 
HSL1152
 Revill J.
 Probe into 'happy pill' after a spate of suicides: Government bows to pressure over Prozac and Seroxat
 The Observer 2003 May 25
 
http://www.guardian.co.uk/politics/2003/may/25/uk.mentalhealth
HSL1149
 FDA Reports More Than Half of Post-Approval Prescription Drug Studies Not Begun
 California Healthline 2003 May 23
 
HSL1140
 Bogdanich W.
 2 Paths of Bayer Drug in 80's: Riskier Type Went Overseas
 New York Times 2003 May 22
 
http://www.nytimes.com/2003/05/22/business/2-paths-of-bayer-drug-in-80-s-riskier-one-steered-overseas.html
HSL1141
 Koppel N.
 Patents Making Drugs Too Expensive
 The Associated Press 2003 May 22
 
HSL1142
 Evans R.
 Campaigners urge world pact to make drugs for poor
 Reuters 2003 May 22
 
HSL1144
 Pugh T.
 Many want to pull plug on The Patient Channel
 Knight Ridder Newspapers 2003 May 22
 
HSL1145
 Silverman E.
 The Canada Connection: Drugs cheaper, if more controversial, through our northern friends
 The Star-Ledger 2003 May 22
 
HSL1146
 Bayer sold risky drug abroad: Drugmaker’s medication spread HIV to consumers overseas
 Associated Press 2003 May 22
 
HSL1136
 Boseley S.
 Guardian on WHO/HAI drug pricing report: Pricing policies exposed
 The Guardian 2003 May 21
 
HSL1137
 Carroll R.
 Africa's Aids drugs trapped in the laboratory: Kenya has the pills. Now the fight is on to get them to the people
 The Guardian 2003 May 21
 
http://www.guardian.co.uk/world/2003/may/21/aids.rorycarroll
HSL1139
 Unprecedented public response to evidence of SSRI drug harm
 BBC Panorama 2003 May 21
 
HSL10487
 Jaffe JH, O'Keeffe C.
 From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States.
 
Drug Alcohol Depend 2003 May 21;70:(2):
 
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T63-4871JJ1-3&_user=10&_coverDate=05%2F21%2F2003&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=13712ceb372225aca8cbc77cce983519
HSL1134
 Goode E.
 Leading Drugs for Psychosis Come Under New Scrutiny
 The New York Times 2003 May 20
 
http://query.nytimes.com/gst/health/article-printpage.html?res=990CE0DB103EF933A15756C0A9659C8B63
HSL1135
 Moyers S.
 Emerson backs bill to allow 'reimport' of U.S. drugs
 Southeast Missourian 2003 May 20
 
HSL1132
 Cook M.
 Time to put drug giants on trial
 The Scotsman 2003 May 19
 
HSL1131
 Berenson A.
 Trial Lawyers Are Now Focusing on Lawsuits Against Drug Makers
 2003 May 18
 
http://query.nytimes.com/gst/fullpage.html?sec=health&res=9406E2DD123EF93BA25756C0A9659C8B63
HSL17956
 Kowalczyk L
 Ruling sought against Pfizer: Federal prosecutors say anticonvulsant marketed illegally
 The Boston Globe 2003 May 18
 
HSL10463
 Treves-Brown KM, Antony FJO, Baker KB, Miller DJS, Young RC, Baird JH
 Supply of veterinary medicines.
 Vet Rec 2003 May 17;152:(20):635
 
HSL10483
 Laing R, Waning B, Gray A, Ford N, 't Hoen E.
 25 years of the WHO essential medicines lists: progress and challenges.
 
Lancet 2003 May 17;361:(9370):1723-9
 
http://linkinghub.elsevier.com/retrieve/pii/S0140673603133752
HSL18152
 Mayor S.
 UK government supports measures to cut drug prices in developing countries.
 BMJ 2003 May 17;326:(7398):1056
 
http://www.bmj.com/cgi/content/full/326/7398/1056-c?view=long&pmid=12750203
HSL18153
 Smith R
 Need good results? Fiddle them
 BMJ 2003 May 17;326:(7398):
 
http://www.bmj.com/cgi/content/full/326/7398/0-e
HSL18155
 Is this journalism that makes a difference? The BBC's Panorama programme  on Seroxat
 BMJ 2003 May 17;326:(7398):1093
 
http://www.bmj.com/cgi/content/full/326/7398/1093
HSL20288
 Morton V, Torgerson DJ
 Effect of regression to the mean on decision making in health care
 BMJ 2003 May 17;326:(7398):1083–1084
 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1125994/
Page 147 of 206 pages ‹ First < 145 146 147 148 149 > Last ›
